| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 258, Issue 3 806-H813, Copyright © 1990 by American Physiological Society
ARTICLES |
J. F. Aceto and K. M. Baker
Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822.
Cardiac hypertrophy is a process that occurs in response to various mechanical or hormonal stimuli. Stimulation of the renin-angiotensin system is involved in the process of cardiac hypertrophy through mechanisms related to increased peripheral vascular resistance and increased cardiac afterload. In this study we determined whether [Sar1]angiotensin II (ANG II) directly stimulated protein synthesis and cell growth in embryonic chick myocytes in cell culture. Eighteen-day-old embryonic chick myocytes in subconfluent cell culture, incubated in a chemically defined serum-free media, showed a significant increase in total protein content, 18.5, 26.2, and 22.2%, respectively, when exposed to [Sar1]ANG II (1 microM/day) for 5, 7, and 9 days, respectively. The increase in total protein resulted in part from an increase in the fractional protein synthesis rate of 21.7, 16.5, and 14.9% at 5, 7, and 9 days, respectively. Total DNA and RNA levels did not change significantly following a 4-day exposure to [Sar1]ANG II in subconfluent culture. The relative rate of protein synthesis, determined by pulse labeling for 3 h with [3H]phenylalanine, showed increases of 23.4, 22.9, and 17.8% over control after 4, 5, and 6 days of exposure to [Sar1]ANG II. The incorporation of [3H]phenylalanine was blocked by the specific ANG II-receptor antagonist [Sar1,Ile8]ANG II. The data demonstrate a receptor-mediated increase in the rate of protein synthesis in cultured chick myocytes in response to [Sar1]ANG II, with a resultant increase in total cellular protein. This angiotensin peptide appears to directly stimulate protein synthesis in cultured embryonic chick myocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. S. Carneiro-Ramos, G. P. Diniz, J. Almeida, R. L. P. Vieira, S. V. B. Pinheiro, R. A. Santos, and M. L. M. Barreto-Chaves Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism J. Physiol., August 15, 2007; 583(1): 213 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. H. Christoffersen, M. Aplin, C. C. Strom, S. P. Sheikh, O. Skott, P. K. Busk, S. Haunso, and L. B. Nielsen Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1635 - H1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Koukoulas, T. Mustafa, R. Douglas-Denton, and E. M. Wintour Angiotensin II receptor (type 1 and 2) expression peaks when placental growth is maximal in sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R972 - R982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Nichols, B. Schuler, M. F. O'Rourke, J. Mathew, P. Sleight, E. Lonn, Q. Yi, J. Pogue, J. Bosch, S. Yusuf, et al. Ramipril and Cardiovascular Risk Reduction * Response Circulation, June 25, 2002; 105 (25): e194 - e195. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Farrell, C.-C. Wei, J. Tallaj, J. L. Ardell, J. A. Armour, G. R. Hageman, W. E. Bradley, and L. J. Dell'Italia Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H813 - H822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Muramatsu, J. Katada, I. Hayashi, and M. Majima Chymase as a Proangiogenic Factor. A POSSIBLE INVOLVEMENT OF CHYMASE-ANGIOTENSIN-DEPENDENT PATHWAY IN THE HAMSTER SPONGE ANGIOGENESIS MODEL J. Biol. Chem., February 25, 2000; 275(8): 5545 - 5552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Narula, P. Pandey, E. Arbustini, N. Haider, N. Narula, F. D. Kolodgie, B. Dal Bello, M. J. Semigran, A. Bielsa-Masdeu, G. W. Dec, et al. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy PNAS, July 6, 1999; 96(14): 8144 - 8149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Thai, H. T. Van, M. A. Gaballa, S. Goldman, and T. E. Raya Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H873 - H880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tamamori, H. Ito, M. Hiroe, Y. Terada, F. Marumo, and M.-A. Ikeda Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2036 - H2040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tamura, S. Umemura, N. Nyui, K. Hibi, T. Ishigami, M. Kihara, Y. Toya, and M. Ishii Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R1 - R9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zou, I. Komuro, T. Yamazaki, S. Kudoh, R. Aikawa, W. Zhu, I. Shiojima, Y. Hiroi, K. Tobe, T. Kadowaki, et al. Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways : Critical Roles of Gß{gamma} Subunit, Src Family, and Ras in Cardiac Fibroblasts Circ. Res., February 23, 1998; 82(3): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Segar, T. D. Scholz, K. A. Bedell, O. M. Smith, D. J. Huss, and E. N. Guillery Angiotensin AT1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1501 - R1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sil Subha Sen Angiotensin II and Myocyte Growth : Role of Fibroblasts Hypertension, August 1, 1997; 30(2): 209 - 216. [Abstract] [Full Text]
|
|
|
|
|
|
E. J. Eichhorn and M. R. Bristow Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure Circulation, November 1, 1996; 94(9): 2285 - 2296. [Abstract] [Full Text]
|
|
|
|
|
|
G. J. Bhat, S. T. Abraham, and K. M. Baker Angiotensin II Interferes with Interleukin 6-induced Stat3 Signaling by a Pathway Involving Mitogen-activated Protein Kinase Kinase 1 J. Biol. Chem., September 13, 1996; 271(37): 22447 - 22452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Dominiczak, A. M. Devlin, W. K. Lee, N. H. Anderson, D. F. Bohr, and J. L. Reid Vascular Smooth Muscle Polyploidy and Cardiac Hypertrophy in Genetic Hypertension Hypertension, March 1, 1996; 27(3): 752 - 759. [Abstract] [Full Text]
|
|
|
|
|
|
B. Fabris, R. Carretta, F. Fischetti, R. Candido, M. Calci, M. Castellano, M. Bardelli, and L. Campanacci Contribution of Systemic Blood Pressure to Myocardial Remodeling in Uremic Rats Hypertension, August 1, 1995; 26(2): 321 - 326. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kohya, H. Yokoshiki, N. Tohse, M. Kanno, H. Nakaya, H. Saito, and A. Kitabatake Regression of Left Ventricular Hypertrophy Prevents Ischemia-Induced Lethal Arrhythmias : Beneficial Effect of Angiotensin II Blockade Circ. Res., May 1, 1995; 76(5): 892 - 899. [Abstract] [Full Text]
|
|
|
|
|
|
K. M. McDonald, J. Mock, A. D'Aloia, T. Parrish, K. Hauer, G. Francis, A. Stillman, and J. N. Cohn Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis Circulation, April 1, 1995; 91(7): 2043 - 2048. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
